The prostacyclin analogue Iloprost as an early predictor of successful revascularization in diabetic patients affected by critical limb ischemia and foot ulcers
Cardiovasc Revasc Med
.
2019 Jul;20(7):621-622.
doi: 10.1016/j.carrev.2019.05.009.
Epub 2019 May 16.
Authors
Michael Patel
1
,
Sofia C D Vianna
1
,
Robert E Beasley
2
Affiliations
1
Mount Sinai Medical Center, 4300 Alton Road, Miami Beach, FL 33140, United States of America.
2
Mount Sinai Medical Center, 4300 Alton Road, Miami Beach, FL 33140, United States of America. Electronic address: bbeaz@aol.com.
PMID:
31175047
DOI:
10.1016/j.carrev.2019.05.009
No abstract available
Publication types
Letter
Comment
MeSH terms
Diabetes Mellitus*
Epoprostenol
Foot Ulcer*
Humans
Iloprost
Ischemia / surgery
Limb Salvage
Substances
Epoprostenol
Iloprost